Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 14/20 | 0.60 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17941667 | 0.98 | SLC5A2 (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL17941664 | 0.98 | SLC5A2 (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL6673371 | 0.87 | SLC5A2 (0.50) | SLC5A2SLC5A1TYR | |
| SCHEMBL15270544 | 0.83 | SLC5A2 (0.62) | SLC5A2SLC5A1TYR | |
| SCHEMBL15269835 | 0.83 | SLC5A2 (0.62) | SLC5A2SLC5A1 | |
| SCHEMBL2917657 | 0.81 | SLC5A2 (0.57) | SLC5A2 | |
| SCHEMBL440403 | 0.80 | SLC5A2 (0.59) | SLC5A2 | |
| SCHEMBL15284566 | 0.80 | SLC5A2 (0.59) | SLC5A2 | |
| SCHEMBL6542524 | 0.80 | SLC5A2 (0.59) | SLC5A2 | |
| SCHEMBL28433449 | 0.80 | SLC5A2 (0.59) | SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180360705-A1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | L'OREAL (FR) | 2018-12-20 | — | — | US | disclosed |
| US-20090263339-A1 | AGENT FOR EXTERNAL APPLICATION TO THE SKIN | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKY (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1894558-A1 | AGENT FOR EXTERNAL APPLICATION TO THE SKIN | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2008-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360705-A1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | KRT18, CUTA, DSG1 | SLC5A2 4840/4885SLC5A1 4794/4885TYR 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.